Hemorrhagic complications of thrombolytic therapy.

Abstract

Stroke is the most frequent neurological disorder, and the most common cause of severe disability compared to other diseases. Recombinant tissue plasminogen activator (rt-PA) is the only approved specific therapy for acute ischemic stroke. Hemorrhage is a significant complication of thrombolytic treatment. This study, which included a hundred patients (52… (More)

Topics

Cite this paper

@article{Vujkovi2012HemorrhagicCO, title={Hemorrhagic complications of thrombolytic therapy.}, author={Zoran Vujkovi{\'c} and Dusko Raci{\'c} and Sinisa Miljkovi{\'c} and Vlado Daji{\'c}}, journal={Medicinski pregled}, year={2012}, volume={65 1-2}, pages={9-12} }